Ask AI
ProCE Banner Activity

Where Lenacapavir Might Fit in the PrEP Toolbox

Clinical Thought

Learn how the recent FDA approval of lenacapavir (LEN) could change the current field of HIV prevention and find out how this new drug could fit into your PrEP toolbox.

Released: August 08, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with American Academy of HIV Medicine, Association of Nurses in AIDS Care (ANAC), and HealthHIV  

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

American Academy of HIV Medicine

ProCE Banner

ANAC

ProCE Banner

HealthHIV

ProCE Banner

Disclosure

Primary Author

Colleen F. Kelley, MD, MPH: researcher: Gilead, Moderna, Novavax, ViiV.

Raphael J. Landovitz, MD, MSc: consultant/advisor: Merck, ViiV.